Fund moves
10.9%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BIAF · NASDAQ · Services-Commercial Physical & Biological Research
$1.85−0.30 (−13.95%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Bioaffinity Technologies (BIAF) · oqro.io/stocks/BIAF · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
No fund reported this stock
No mutual fund or ETF listed it in its latest public N-PORT report. Funds report each quarter, about two months after the quarter ends.